BACKGROUND: Tissue transglutaminase (t-TG) has been implicated in small artery remodelling. The aim of this study was to determine if cystamine, an inhibitor of t-TG, could reduce blood pressure in spontaneously hypertensive rats (SHR) and if so to what extent this is mediated through small arteries. METHODS: In vitro inhibition of t-TG, with cystamine, was studied in organ culture and wire myograph setups in small mesenteric arteries obtained from SHR. In vivo treatment with cystamine (80 mg/kg/day) or amlodipine (10 mg/kg/day) was performed with osmotic pumps in adult SHR, and hemodynamic parameters determined with telemetry. Plasma concentrations of cystamine were determined with a liquid chromatography setup. Small arteries were harvested following administration of cystamine, and structural as well as functional characteristics were determined. RESULTS: SHR small arteries showed inward remodelling following in vitro activation. Administration of cystamine caused attenuation of the inward remodelling induced by activation. In vivo administration of cystamine caused a 9 ± 2 mm Hg reduction in blood pressure, but with no detectable alterations in small artery structure. CONCLUSION: t-TG is potentially involved in vascular remodelling of SHR small arteries and results support a possible role for t-TG in blood pressure control.
BACKGROUND: Tissue transglutaminase (t-TG) has been implicated in small artery remodelling. The aim of this study was to determine if cystamine, an inhibitor of t-TG, could reduce blood pressure in spontaneously hypertensiverats (SHR) and if so to what extent this is mediated through small arteries. METHODS: In vitro inhibition of t-TG, with cystamine, was studied in organ culture and wire myograph setups in small mesenteric arteries obtained from SHR. In vivo treatment with cystamine (80 mg/kg/day) or amlodipine (10 mg/kg/day) was performed with osmotic pumps in adult SHR, and hemodynamic parameters determined with telemetry. Plasma concentrations of cystamine were determined with a liquid chromatography setup. Small arteries were harvested following administration of cystamine, and structural as well as functional characteristics were determined. RESULTS: SHR small arteries showed inward remodelling following in vitro activation. Administration of cystamine caused attenuation of the inward remodelling induced by activation. In vivo administration of cystamine caused a 9 ± 2 mm Hg reduction in blood pressure, but with no detectable alterations in small artery structure. CONCLUSION: t-TG is potentially involved in vascular remodelling of SHR small arteries and results support a possible role for t-TG in blood pressure control.
Authors: Humphrey G Petersen-Jones; Kyle B Johnson; Kiyotaka Hitomi; Nathan R Tykocki; Janice M Thompson; Stephanie W Watts Journal: Am J Physiol Heart Circ Physiol Date: 2015-01-16 Impact factor: 4.733
Authors: Chen Liu; Wei Wang; Nicholas Parchim; Roxanna A Irani; Sean C Blackwell; Baha Sibai; Jianping Jin; Rodney E Kellems; Yang Xia Journal: Hypertension Date: 2013-11-04 Impact factor: 10.190
Authors: Sung Mee Jung; Simran Jandu; Jochen Steppan; Alexey Belkin; Steven S An; Alina Pak; Eric Y Choi; Daniel Nyhan; Mark Butlin; Kayla Viegas; Alberto Avolio; Dan E Berkowitz; Lakshmi Santhanam Journal: Am J Physiol Heart Circ Physiol Date: 2013-07-19 Impact factor: 4.733
Authors: Christopher A Foote; Jorge A Castorena-Gonzalez; Marius C Staiculescu; Philip S Clifford; Michael A Hill; Gerald A Meininger; Luis A Martinez-Lemus Journal: Am J Physiol Heart Circ Physiol Date: 2015-11-13 Impact factor: 4.733
Authors: Renna Luo; Chen Liu; Serra E Elliott; Wei Wang; Nicholas Parchim; Takayuki Iriyama; Patrick S Daugherty; Lijian Tao; Holger K Eltzschig; Sean C Blackwell; Baha M Sibai; Rodney E Kellems; Yang Xia Journal: J Am Heart Assoc Date: 2016-06-30 Impact factor: 5.501